Investor Alert

London Markets Open in:

Intra-Cellular Therapies Inc.



After Hours

 --Quotes are delayed by 20 min

Sep 27, 2022, 4:44 p.m.





0.00 0.00%


Volume 22,593

Quotes are delayed by 20 min


Previous close

$ 42.70

$ 44.58


+1.88 +4.40%

Day low

Day high




52 week low

52 week high




Annual Financials for Intra-Cellular Therapies Inc.


Fiscal year is January-December. All values USD millions. 20172018201920202021 5-year trend
Cash & Short Term Investments 464.33M347.53M224.01M658.85M413.73M
Cash Only 37.79M54.95M107.64M61.45M93.76M
Short-Term Investments -----
Total Accounts Receivable ---10.76M20.16M
Accounts Receivables, Net ---10.76M20.16M
Accounts Receivables, Gross 0--10.88M20.16M
Bad Debt/Doubtful Accounts ---(120,000)-
Other Receivables -----
Inventories ---7.06M7.95M
Finished Goods ---2.79M3.06M
Work in Progress ---1.78M2.41M
Raw Materials ---2.48M2.48M
Progress Payments & Other -----
Other Current Assets 4.88M7.91M6.31M14.24M25.44M
Miscellaneous Current Assets 4.88M7.91M6.31M14.24M25.44M
Total Current Assets 469.22M355.44M230.32M690.9M467.28M
20172018201920202021 5-year trend
Net Property, Plant & Equipment 1.14M1.16M20.51M26.32M22.56M
Property, Plant & Equipment - Gross 3.83M4.19M24.02M30.36M27.12M
Buildings -----
Land & Improvements -----
Computer Software and Equipment 33,58444,427243,532243,532408,751
Other Property, Plant & Equipment 301,509491,0521.66M1.66M1.66M
Accumulated Depreciation 2.69M3.03M3.51M4.04M4.57M
Total Investments and Advances -----
Other Long-Term Investments -----
Long-Term Note Receivable -----
Intangible Assets -----
Net Goodwill -----
Net Other Intangibles -----
Other Assets 75,76078,83086,08086,08086,080
Tangible Other Assets 75,76578,83386,08486,08486,084
Total Assets 471.49M357.21M251.19M717.31M489.92M

Liabilities & Shareholders' Equity

20172018201920202021 5-year trend
ST Debt & Current Portion LT Debt --3.19M5.54M6.73M
Short Term Debt --3.19M3.28M-
Current Portion of Long Term Debt ---2.26M3.41M
Accounts Payable 6.17M13.96M7.43M5.5M8.69M
Income Tax Payable -----
Other Current Liabilities 8.04M22.34M25.61M25.81M37.93M
Dividends Payable -----
Accrued Payroll 1.61M2.29M9.47M14.91M20.9M
Miscellaneous Current Liabilities 6.42M20.04M16.14M10.9M17.04M
Total Current Liabilities 14.21M36.3M36.22M36.85M53.36M
Long-Term Debt --19.96M23.6M18.67M
Long-Term Debt excl. Capitalized Leases -----
Non-Convertible Debt -----
Convertible Debt -----
Capitalized Lease Obligations ---5.04M1.68M
Provision for Risks & Charges -----
Deferred Taxes (1.06M)(529,218)(264,609)--
Deferred Taxes - Credit -----
Deferred Taxes - Debit 1.06M529,218264,609--
Other Liabilities 2.84M3.19M---
Other Liabilities (excl. Deferred Income) 2.84M3.19M---
Deferred Income -----
Total Liabilities 17.05M39.49M56.18M60.45M72.03M
Non-Equity Reserves -----
Preferred Stock (Carrying Value) -----
Redeemable Preferred Stock -----
Non-Redeemable Preferred Stock -----
Common Equity (Total) 454.44M317.71M195.01M656.86M417.89M
Common Stock Par/Carry Value 5,4605,4905,5518,0468,189
Retained Earnings (407.25M)(562.38M)(710.1M)(937.1M)(1.22B)
ESOP Debt Guarantee -----
Cumulative Translation Adjustment/Unrealized For. Exch. Gain -----
Unrealized Gain/Loss Marketable Securities --128,317480,584(363,653)
Revaluation Reserves -----
Treasury Stock -----
Total Shareholders' Equity 454.44M317.71M195.01M656.86M417.89M
Accumulated Minority Interest -----
Total Equity 454.44M317.71M195.01M656.86M417.89M
Liabilities & Shareholders' Equity 471.49M357.21M251.19M717.31M489.92M
Link to MarketWatch's Slice.